Correlation Between Shanghai Rightongene and Shenzhen Bioeasy

Can any of the company-specific risk be diversified away by investing in both Shanghai Rightongene and Shenzhen Bioeasy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shanghai Rightongene and Shenzhen Bioeasy into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Shanghai Rightongene Biotechnology and Shenzhen Bioeasy Biotechnology, you can compare the effects of market volatilities on Shanghai Rightongene and Shenzhen Bioeasy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shanghai Rightongene with a short position of Shenzhen Bioeasy. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shanghai Rightongene and Shenzhen Bioeasy.

Diversification Opportunities for Shanghai Rightongene and Shenzhen Bioeasy

0.74

Correlation Coefficient

Shanghai Rightongene  Shenzhen Bioeasy

Poor diversification

The 3 months correlation between Shanghai and Shenzhen is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Shanghai Rightongene Biotechno and Shenzhen Bioeasy Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shenzhen Bioeasy Bio and Shanghai Rightongene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shanghai Rightongene Biotechnology are associated (or correlated) with Shenzhen Bioeasy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shenzhen Bioeasy Bio has no effect on the direction of Shanghai Rightongene i.e., Shanghai Rightongene and Shenzhen Bioeasy go up and down completely randomly.

Pair Corralation between Shanghai Rightongene and Shenzhen Bioeasy

Assuming the 90 days trading horizon Shanghai Rightongene Biotechnology is expected to generate 1.34 times more return on investment than Shenzhen Bioeasy. However, Shanghai Rightongene is 1.34 times more volatile than Shenzhen Bioeasy Biotechnology. It trades about -0.17 of its potential returns per unit of risk. Shenzhen Bioeasy Biotechnology is currently generating about -0.29 per unit of risk. If you would invest  2,100  in Shanghai Rightongene Biotechnology on October 7, 2024 and sell it today you would lose (335.00) from holding Shanghai Rightongene Biotechnology or give up 15.95% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Shanghai Rightongene Biotechno  vs.  Shenzhen Bioeasy Biotechnology

Shanghai Rightongene

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Shanghai Rightongene Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Shenzhen Bioeasy Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Shenzhen Bioeasy Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Shanghai Rightongene and Shenzhen Bioeasy

The main advantage of trading using opposite Shanghai Rightongene and Shenzhen Bioeasy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shanghai Rightongene position performs unexpectedly, Shenzhen Bioeasy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shenzhen Bioeasy will offset losses from the drop in Shenzhen Bioeasy's long position.

The idea behind Shanghai Rightongene Biotechnology and Shenzhen Bioeasy Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.